OTC · Financial Statements
Decision Diagnostics Corp. (DECN) Financial Statements
$0.00
OTC: DECN
Market Cap $35787
Overview Financials Dividend Decision Diagnostics Corp. most recently reported annual revenue of $2.0M, a net loss of $30.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2016 2017 2018 2019 2020 Revenue $1.0M $2.0M $2.0M $2.0M $2.0M Operating Profit $-3.0M $-2.0M $-2.0M $-1.0M $-2.0M Net Profit $-3.0M $-3.0M $-2.0M $-3.0M $-30.0M EPS $-0.04 $-0.03 $-0.02 $-0.02 $-0.11 Op Margin -361.9% -125.8% -82.9% -54.4% -106.7%
Balance Sheet (USD)
Metric 2016 2017 2018 2019 2020 Total Assets $6.0M $5.0M $4.0M $5.0M $6.0M Total Liabilities $4.0M $3.0M $3.0M $5.0M $5.0M Cash $1.0M $1.0M $0 $0 $1.0M Borrowings $2.0M $2.0M $2.0M $3.0M $3.0M
Cash Flow (USD)
Metric 2016 2017 2018 2019 2020 Operating Cash Flow $-3.0M $-2.0M $-1.0M $-1.0M $-1.0M Investing Cash Flow $-1.0M $0 $0 $0 $0 Financing Cash Flow $0 $0 $0 $0 $0 Net Cash Flow $1.0M $0 $-1.0M $-1.0M $1.0M Free Cash Flow $-3.0M $-2.0M $-1.0M $-1.0M $-1.0M
Valuation & Return Ratios
Metric Value PEG Ratio 0.00 EV / EBITDA -1.01 FCF Yield -3925.93% Quick Ratio 0.30 Interest Coverage -0.08 Return 1Y 0.00% Return 3Y 0.00% Return 5Y —
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer .